Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Genera Biosystems Ltd (GBI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12156
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is a molecular diagnostic test for the detection and genotyping of high risk and low risk types of human papillomavirus that cause cervical cancer or genital warts. GBL uses AmpaSand beads technology to create identifiable clusters of beads that can be distinguished in a conventional flow cytometer. The company provides products to detect influenzaA, influenzaB, influenza A H1N1, influenzaA H5N1, respiratory syncytial virus, human metapneumovirus, adenovirus, rhinovirus, bordetella pertussis, and chlamydophila pneumonia. It collaborates with pathology customers and IVD companies. GBL is headquartered in Melbourne, Victoria, Australia.

Genera Biosystems Ltd (GBI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genera Biosystems Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Genera Biosystems Enters into Distribution Agreement with Beckman Coulter Life Sciences 10
Genera Biosystems Enters into Co-Marketing Agreement with Beckman Coulter Life Sciences 11
Genera Biosystems Enters into Distribution Agreement with Genecell Diagnostics 12
Equity Offering 13
Genera Biosystems Announces Private Placement of Shares for USD0.5 Million 13
Genera Biosystems Completes Private Placement Of Shares For US$0.12 Million 14
Genera Biosystems Raises USD1.01 Million in Rights Issue Of Shares 15
Debt Offering 16
Genera Biosystems Raises USD0.5 Million in Second Tranche of Private Placement of Notes 16
Genera Biosystems Raises USD1.6 Million in First Tranche of Private Placement of Notes 17
Genera Biosystems Completes Private Placement of Notes for USD0.3 Million 18
Genera Biosystems Raises USD0.2 Million in Private Placement of Notes Due 2015 19
Genera Biosystems Completes Private Placement Of Notes Due 2015 For US$0.34 Million 20
Genera Biosystems Ltd – Key Competitors 21
Genera Biosystems Ltd – Key Employees 22
Genera Biosystems Ltd – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Nov 01, 2018: Genera Biosystems: Quarterly cash flow & business update for 30th June 2018 24
Corporate Communications 25
Nov 30, 2018: Genera Biosystems: changes to the board of directors 25
Other Significant Developments 26
May 01, 2018: Genera Biosystems:Quarterly Cash Flow & Business Update 26
Nov 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update 27
Jul 31, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update 28
May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017 30
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Genera Biosystems Ltd, Medical Equipment, Key Facts, 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Deals By Market, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genera Biosystems Enters into Distribution Agreement with Beckman Coulter Life Sciences 10
Genera Biosystems Enters into Co-Marketing Agreement with Beckman Coulter Life Sciences 11
Genera Biosystems Enters into Distribution Agreement with Genecell Diagnostics 12
Genera Biosystems Announces Private Placement of Shares for USD0.5 Million 13
Genera Biosystems Completes Private Placement Of Shares For US$0.12 Million 14
Genera Biosystems Raises USD1.01 Million in Rights Issue Of Shares 15
Genera Biosystems Raises USD0.5 Million in Second Tranche of Private Placement of Notes 16
Genera Biosystems Raises USD1.6 Million in First Tranche of Private Placement of Notes 17
Genera Biosystems Completes Private Placement of Notes for USD0.3 Million 18
Genera Biosystems Raises USD0.2 Million in Private Placement of Notes Due 2015 19
Genera Biosystems Completes Private Placement Of Notes Due 2015 For US$0.34 Million 20
Genera Biosystems Ltd, Key Competitors 21
Genera Biosystems Ltd, Key Employees 22

List of Figures
Genera Biosystems Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NGK Spark Plug Co Ltd:戦略・SWOT・企業財務分析
    NGK Spark Plug Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NGK Spark Plug Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pakistan International Airlines Corporation
    Pakistan International Airlines Corporation - Strategy, SWOT and Corporate Finance Report Summary Pakistan International Airlines Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Vascular Concepts Ltd:企業の製品パイプライン分析2018
    Summary Vascular Concepts Ltd (Vascular Concepts) formerly known as Medical Concepts Ltd is a medical device company that designs, develops and manufactures endovascular medical devices for the treatment of arterial diseases. Its products include coronary stents, peripheral stents and balloon. Vascu …
  • Toro Energy Limited (TOE):企業の戦略的SWOT分析
    Toro Energy Limited (TOE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mevion Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Mevion Medical Systems Inc (Mevion), formerly Still River Systems is a medical equipment company that offers therapy systems. The company offers radiation therapy and proton therapy systems for the treatment of cancer. It provides MEVION S250 proton therapy system designed for preserving tre …
  • DermTech Inc-医療機器分野:企業M&A・提携分析
    Summary DermTech Inc (DermTech) is a precision medicine developer that offers molecular tests. The company’s products include adhesive skin sample collection kit and pigmented lesion assay. Its EGIR platform technology is applicable in non-invasive, genomic-based disease detection, theranostics, pha …
  • GW Pharmaceuticals Plc (GWP)-医療機器分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • Aohata Corporation:企業の戦略・SWOT・財務情報
    Aohata Corporation - Strategy, SWOT and Corporate Finance Report Summary Aohata Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nizhnekamskneftekhim (NKNC):企業の財務・戦略的SWOT分析
    Nizhnekamskneftekhim (NKNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cogeco Inc:企業の戦略・SWOT・財務情報
    Cogeco Inc - Strategy, SWOT and Corporate Finance Report Summary Cogeco Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Apache Corporation:企業の戦略・SWOT・財務分析
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Efore Oyj (EFO1V):企業の財務・戦略的SWOT分析
    Efore Oyj (EFO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ELITechGroup Inc:医療機器:M&Aディール及び事業提携情報
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cystic fibrosis, hematology, microbiology and molecular diagnostics. Its clinical chemistry produ …
  • Arkansas Children’s Hospital:企業の戦略的SWOT分析
    Arkansas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Zirax Ltd:企業の戦略的SWOT分析
    Zirax Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • Berkem SA:企業の戦略・SWOT・財務情報
    Berkem SA - Strategy, SWOT and Corporate Finance Report Summary Berkem SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Shandong Weigao Group Medical Polymer Company Ltd (1066):企業の財務・戦略的SWOT分析
    Shandong Weigao Group Medical Polymer Company Ltd (1066) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company …
  • Hotel Excelsior d.d.:企業の戦略・SWOT・財務分析
    Hotel Excelsior d.d. - Strategy, SWOT and Corporate Finance Report Summary Hotel Excelsior d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • China Telecom Corporation Limited:戦略・SWOT・企業財務分析
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆